IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
Yang Zhao(École Polytechnique Fédérale de Lausanne), Li Tang(École Polytechnique Fédérale de Lausanne), Yuqing Xie(École Polytechnique Fédérale de Lausanne), Yi Wang(École Polytechnique Fédérale de Lausanne), Mathias Wenes(University of Geneva), Bing Feng(Chinese Academy of Sciences), Yugang Guo(University of Science and Technology of China), Jiangqing Chen(First Affiliated Hospital Zhejiang University), Xiaomeng Hu(Southwest University), Jie Sun(North Sichuan Medical University), Min Gao(Central South University), Massimo Andreatta(University of Geneva), Pedro Romero(TiGenix (Spain)), Santiago J. Carmona(University of Geneva)
Cited by 258
Related Papers
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
|Science|1996|1.3k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k
UCell: Robust and scalable single-cell gene signature scoring
|Computational and Structural Biotechnology Journal|2021|1k
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
|Nature Biotechnology|2018|641
Interpretation of T cell states from single-cell transcriptomics data using reference atlases
|Nature Communications|2021|573